6 results match your criteria: "Šibenik-Knin County General Hospital[Affiliation]"

Background/aims: Hepatitis B core antibody (HBcAb) positivity of the donor or the recipient may pose a risk of hepatitis B virus (HBV) reactivation following liver transplantation (LT). We retrospectively investigated patient survival and reactivation among recipients who were given low-dose Hepatitis B Immune Globulin (HBIG) plus antiviral agent (AV) versus AV only.

Materials And Methods: Records of cadaveric LT recipients, between 2013 and 2016, with positive Hepatitis B surface Antigen (HBsAg) and/or HBcAb and recipients who had received LT from HBcAb-positive donors were reviewed.

View Article and Find Full Text PDF

In 1867, Joseph Lister wrote this account of how to prepare the skin for surgery: "A solution of one part crystallised carbolic acid in four parts of boiled linseed oil having been prepared, a piece of rag from four to six inches square is dipped in the oily mixture, and laid upon the skin where the incision is to be made." Nearly 150 years later, the science of preoperative skin preparation has grown more sophisticated, but continues to be the cornerstone of evidence-based practices to prevent surgical site infections (SSIs) and promote positive surgical outcomes.

View Article and Find Full Text PDF

Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study.

Ann Surg

January 2010

University of Southern California-Keck School of Medicine, Department of Surgery-Division of Acute Care Surgery (Emergency Surgery, Trauma, and Surgical Critical Care), Los Angeles County General Hospital (LAC + USC), 1200 North State St, C4E100, Los Angeles, CA 90033, USA.

Objective: Erythropoiesis stimulating agent (ESA) administration may reduce mortality in severe traumatic brain injury (sTBI).

Summary Background Data: It has been established that the administration of ESA in critically ill trauma victims has been associated with improved outcomes. Recent experimental and clinical data showed neuroprotective effects of ESA, however, the literature regarding impact on outcome in sTBI is lacking.

View Article and Find Full Text PDF

Dosage, pharmacological effects and clinical outcomes for bivalirudin in percutaneous coronary intervention.

J Invasive Cardiol

December 2000

Cardiac Catheterization Laboratory, Jackson-Madison County General Hospital, Medical Specialties Clinic, 27 Medical Center Drive, Jackson, TN 38301, USA.

View Article and Find Full Text PDF